MBX Biosciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-42.6M | — |
| Mar 2023 | — | $-48.3M | — |
| Jun 2023 | — | $-55.4M | — |
| Sep 2023 | — | $-64.8M | — |
| Dec 2023 | — | $-72.5M | $30.5M |
| Mar 2024 | — | $-83.0M | — |
| Jun 2024 | — | $-97.9M | — |
| Sep 2024 | — | $271.4M | $132.9M |
| Dec 2024 | — | $257.4M | $49.4M |
| Mar 2025 | — | $235.4M | $29.9M |
| Jun 2025 | — | $219.2M | $39.8M |
| Sep 2025 | — | $387.5M | $223.1M |
| Dec 2025 | — | $369.2M | $75.3M |
| Mar 2026 | — | $437.8M | $45.2M |
| Jun 2026 | — | $409.5M | $54.1M |